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Abstract 
Background: To assess the association between 
insulin resistance, thyroid profile and glucose levels 
in type 2 diabetes mellitus. 
Methods:  In this randomized control trial, 60 
Sprague Dawley rats were  divided into control and 
diabetic groups. All the rats were checked for 
euglycemia and euthyroidism at the beginning of the 
study by analyzing plasma glucose and serum 
thyroid stimulating hormone (TSH) levels. The 
diabetic group was fed high fat diet while control 
group was given normal pellet diet. After 2 weeks 
diabetic rats were intraperitoneally administered 
low dose of streptozotocin and saline to the control 
group. Development of type 2 diabetes was 
confirmed by checking homeostatic model for 
insulin resistance (HOMA-IR) and plasma glucose 
levels. Specific diet for the two groups was 
continued for another five weeks. Terminal blood 
samples were  analyzed for plasma glucose, serum 
insulin, T3, T4 and TSH levels. 
Results: Plasma glucose and serum insulin levels 
were found significantly elevated (p-0.001) in the 
diabetic group. HOMA-IR was increased in the 
diabetic group (p=0.001). Serum T4 and TSH levels 
were significantly elevated (p=0.001) while no 
significant change in serum T3 was noticed in the 
diabetic group. Pearson correlation coefficient 
revealed positive correlation between insulin 
resistance and T4 level (r=0.36) in the diabetic group. 
Positive correlation was found in the diabetic group 
between glucose level and T3 (r=0.36) and plasma 
glucose and T4 (r=0.35). 
Conclusion: Development of thyroid dysfunction 
and insulin resistance interplay in development of 
hyperglycemia in type 2 diabetes mellitus.  
Key Words: Type 2 diabetes mellitus, thyroid 
hormones, insulin resistance  
 
Introduction 
     Little is known about the relationship between 
thyroid function and insulin resistance. With thyroid 
hormone concentration in normal range, even minor 
differences seem to be significant. Thyroid hormones 
have been documented to be associated with insulin 
resistance even in euthyroid range.1  
     Insulin resistance, a cardinal feature of Type 2 
Diabetes Mellitus (T2DM), is characterized by 
impaired ability of insulin to inhibit hepatic glucose 
output and to stimulate glucose uptake.2 Patients with 
T2DM have been documented to have similar 
prevalence of hypothyroidism or hyperthyroidism as 
that in general population.3 Increased insulin 
resistance has been associated with higher circulating 
levels of insulin which leads to the increased thyroid 
proliferation.4 
    Insulin and thyroid hormones play an important 
role in glucose homeostasis.5 A complex mechanism 
involving, food intake, regulation of insulin secretion 
and its action on target tissues help in achieving 
glucose homeostasis. Action of thyroid hormones is an 
important determinant of glucose homeostasis.6 It has 
been studied that both triiodothyronine (T3) and 
insulin stimulate the expression of hexokinases and 
glycogen synthase which are respectively responsible 
for the uptake and disposal of glucose via the 
formation of glucose-6-phosphate and glucose-1-
phosphate.7 Contrarily thyroid hormones oppose the 
action of insulin by stimulating gluconeogenesis and 
glycogenolysis, regulate the expression of genes such 
as GLUT-4 and phosphoglycerate kinase, involved in 
glucose transport and glycolysis respectively, and act 
synergistically with insulin in glucose uptake and 
disposal in peripheral tissues.8,9   
    Studies have shown that triiodothyronine (T3) 
stimulate GLUT4 messenger RNA and protein 
expression in skeletal muscle and elevates basal 
glucose uptake.10 Low normal serum free thyroxine 
(FT4) levels are significantly associated with high 
insulin resistance and subjects with low normal 
thyroid function have increased risk of cardiovascular 
diseases.11 Studies have suggested higher levels of 
total thyroxine (TT4) within euthyroid range in 
diabetic subjects as compared to the control group. 
Increased TT4 is related to abnormal glycemic levels 
and insulin resistance indicating the involvement of 
thyroid gland in insulin resistance.12 The present study 
Journal of Rawalpindi Medical College (JRMC); 2013;17(2):277-280 
 
 278 
is designed to study thyroid hormone levels and 
insulin resistance in type 2 diabetic rats. 
Material and Methods 
The study was conducted on 60 healthy 
Sprague Dawley rats. Average weight of each rat was 
250 ± 50 grams. Diabetic rats were excluded at the start 
of the study by estimating plasma glucose levels by 
glucometer . Rats with thyroid disease were excluded 
by measuring serum TSH levels .The rats were 
randomly divided into two groups, each having 30 
rats. Rats in control group were fed on normal pellet 
diet and diabetic group was fed high fat diet and 
water ad libitum. After 2 weeks, an intraperitoneal 
injection of streptozotocin was administered to 
diabetic group and normal saline to the control group. 
HOMA-IR was calculated after 1 week to confirm the 
induction of T2DM by taking tail vein blood sample. 
Afterwards, rats were continued with the same diet for 
next 5 weeks.13  
     At the end of study, rats were placed one by one in 
a closed glass chamber containing ether soaked cotton 
in the main laboratory of animal house for intracardiac 
sampling and blood was drawn with the help of 5.0 ml 
disposable syringe.14,15 After centrifugation, the plasma 
was pipetted out of the sodium fluoride tubes and put 
in the polypropylene storage tube.Plasma glucose was 
estimated by glucose oxidase method and serum 
insulin was done by ELISA technique . Serum T3, T4 
and TSH levels were assayed by  ELISA. The statistical 
significance of differences between the control and 
diabetic groups was determined by applying 
independent sample’s t-test. p-value≤0.05 was 
considered significant. Pearson correlation coefficient 
was worked out to find correlation between insulin 
resistance, thyroid profile and glucose levels. 
Results 
     The blood glucose and TSH levels were checked at 
the beginning of the study which revealed that all the 
rats of the two groups were euthyroid (TSH=0.36 
µU/ml) and euglycemic (glucose=94.24 mg/dl). 
Plasma glucose level more than 200mg/dl and 
HOMA-IR more than 2 in the diabetic group 
confirmed the development of T2DM (Table 1). 
The comparison of plasma glucose, serum 
insulin, HOMA-IR and thyroid profile of the control 
and diabetic groups at the end of study period (8th 
week)  revealed significant difference in plasma 
glucose levels between the two groups (p<0.001). 
Serum insulin levels were significantly raised in the 
diabetic group (p<0.001) (Table 2). HOMA-IR of the 
diabetic group (16.37±0.41) was significantly higher  
Table 1: Comparison of fasting plasma glucose, 
serum insulin and HOMA-IR between diabetic and 
control groups at the end of 3rd week 
Variables Control(n=30) Diabetic (n=30) p-value 
Glucose(mg/dl) 93.13 ± 1.55 268.46 ± 5.09 <0.001 
Insulin (µU/l) 1.404 ± 0.04 15.860 ± 0.338 <0.001 
HOMA-IR 0.321±0.009 8.878 ± 0.212 <0.001 
All values have been expressed as Mean ± SEM 
 
Table 2: Comparison of plasma glucose, serum 
insulin, HOMA-IR and thyroid profile of control 
and diabetic groups at the end of the study 
Variables Control 
(n=30) 
Diabetic 
(n=30) 
p-value 
Plasma glucose 
(mg/dl) 95.46 ± 10.00 297.73 ± 27.05 <0.001 
Serum insulin 
(µU/ml) 1.42 ± 0.03 22.29 ± 0.49 <0.001 
HOMA-IR 
 0.33 ± 0.24 16.37 ± 0.41 <0.001 
Serum T3 
(ng/ml) 4.57 ± 0.30 4.60 ± 0.12 0.920 
Serum T4 
(ng/ml) 59.9 ± 2.00 171.73 ± 2.66 <0.001 
Serum TSH 
(µU/ml) 0.354± 0.027 0.924±0.007 <0.001 
All values have been expressed as Mean ± SEM 
 
Table 3: Pearson correlation coefficient of HOMA-IR 
and glucose with T3, T4 and TSH in control and 
diabetic groups at the end of the study 
Parameters 
 
Group 1 Group  2 
r-value p-value r-value p-value 
HOMA-IR 
T3 -0.12 0.50 0.25 0.17 
T4 -0.15 0.93 0.36 0.04 
TSH 0.49 0.006 -0.17 0.36 
Glucose 
T3 -0.04 0.83 0.36 0.05 
T4 0.029 0.87 0.35 0.05 
TSH 0.35 0.05 0.10 0.56 
p-value ≤ 0.05 was considered significant 
 
(p<0.001) as compared to the control group 
(0.335±0.24). There was no change in serum T3 levels 
in the diabetic group however serum T4 and TSH 
levels were found significantly raised (p<0.001) in the 
diabetic group as compared to the control.Pearson 
correlation coefficient between insulin resistance, 
thyroid profile and glucose levels in the control and 
diabetic groups  showed strong positive correlation 
between HOMA-IR and T4 (r=0.36, p=0.04). Positive 
correlation was found between plasma glucose, T3 and 
T4 in the diabetic group (Table 3).  
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Discussion 
     The interplay of insulin and thyroid hormones in 
maintaining glucose homeostasis in type 2 diabetes 
mellitus was observed in the present study. The 
animal model closely resembling the metabolic 
characteristics of type 2 diabetic human was used in 
the study. The induction of T2DM was confirmed by 
the development of hyperglycemia (268.46 ± 5.09 
mg/dl) and insulin resistance manifested by 
hyperinsulinemia (15.86 ± 0.338 µU/l) and raised 
HOMA-IR (8.878 ± 0.212). 
    The study was carried out for a period of 8 weeks 
after which the analysis of terminal blood samples 
revealed hyperglycemia (297.73±27.05 mg/dl), 
hyperinsulinemia (22.29±0.49 µU/l)  and elevated 
HOMA-IR (16.37 ± 0.41) in the diabetic rats. In a study 
conducted by Srinivasan et al(2005), Sprague Dawley 
rats developed hyperglycemia which was similar to 
the finding in our study. A study on the magnitude of 
hyperglycemia and oxidative stress in experimental 
diabetic rats revealed elevated blood glucose levels 
after high fat diet (22% fat) and I/P injection of STZ in 
the dose of 10mg/kg body weight daily.16  
    Induction of T2DM and insulin resistance in 
Sprague Dawley rats, by feeding high fructose diet 
(60% fructose) for 4 weeks, without administration of 
STZ, led to raised insulin levels were raised.17 The rise 
in insulin level in present  study was much higher.It 
can be ascribed to the prolonged duration (8 weeks) 
for which high fat diet was fed to the diabetic rats even 
after the development of T2DM. In an animal model of 
T2DM two groups of male Sprague Dawley rats were 
studied. One group was fed normal chow and the 
other group was fed high fat diet for a period of two 
weeks. Analysis of blood samples of both the groups 
revealed increased level of serum insulin in fat fed 
STZ rats as compared to chow fed STZ rats.18 This 
finding revealed that high fat diet contributed to the 
induction of insulin resistance which resulted in raised 
level of serum insulin.  
     Raised HOMA-IR (16.37 ± 0.41) in the diabetic rats 
of present study indicated the presence of insulin 
resistance which was comparable to the taurine 
supplemented type 2 diabetic OLETF rats. At the end 
of 12 weeks of the study it was found that HOMA-IR 
was high in diabetic rats.19 The effect of fish oil and 
olive oil on insulin resistance had been studied in male 
Wistar rats. It was observed that in rats fed on high 
fat-butter diet developed significantly higher (p<0.05) 
insulin resistance.20 Male Sprague Dawley rats were 
given high fat diet containing 41.2 % fat and a single 
intraperitoneal injection of STZ (40mg/kg). Sampling 
done after a period of 8 weeks revealed an elevated 
HOMA-IR in the diabetic rats, comparable to the 
HOMA-IR of diabetic group of our study. 21 As insulin 
is known to have a stimulatory effect on proliferation 
of thyrocytes, low levels of insulin can lead to  
decreased level of thyroid hormones specially T4 in 
their study.22,23 
     Screening of diabetic subjects for thyroid 
dysfunction revealed that 17% patients had high total 
T4 while fT4 and total T3 and fT3 levels did not differ 
much. 28% diabetic patients had low plasma thyroid 
hormones level.24 These findings could be due to the 
reason that the subjects in their study were on oral 
hypoglycemics and insulin therapy. Phenylthioureas 
are known to decrease the levels of fT4 and TT4 while 
exogenous insulin administration increases the level of 
fT4 and decreases T3 by inhibiting the hepatic 
conversion of T4 into T3.25 Glycemic status is known to 
alter TRH and TSH levels, therefore the presence of 
raised and low levels of thyroid hormones in different 
patients of their study, reflected the glycemic status of 
these diabetic patients.26  
     High levels of circulating insulin in type 2 diabetes 
results in thyroid gland proliferation and formation of 
thyroid nodules. Insulin and insulin like growth factor 
(IGF1) have been known to modulate the regulation of 
thyroid gene expression and is considered an 
important factor in thyrocyte proliferation and 
differentiation.27 A study conducted to assess the 
association between insulin resistance and thyroid 
hormones in subjects having subclinical thyrotoxicosis 
revealed T4 and free T4 levels on the higher side of the 
normal range.28 -30 
 
Conclusion 
Glucose levels and insulin resistance is positively 
associated with thyroid hormone levels in STZ 
induced T2DM.   
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